Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Chemistry

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1373/CLINCHEM.2012.190199PMID 22912397
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faculty Opinions recommendation of Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.

  2011cited by this paper
• Resolvin D2 Is a Potent Endogenous Inhibitor for Transient Receptor Potential Subtype V1/A1, Inflammatory Pain, and Spinal Cord Synaptic Plasticity in Mice: Distinct Roles of Resolvin D1, D2, and E1

  2011cited by this paper
• Novel anti-inflammatory--pro-resolving mediators and their receptors.

  2011cited by this paper
• Emerging roles of resolvins in the resolution of inflammation and pain.

  2011cited by this paper
• Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.

  2011cited by this paper
• Omega-3 Fatty Acid-Derived Mediators 17(R)-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice

  2011cited by this paper
• MicroRNAs in resolution of acute inflammation: identification of novel resolvin Dl‐miRNA circuits

  2011cited by this paper
• Resolvins and protectins in inflammation resolution.

  2011cited by this paper
• Resolvins are potent analgesics for arthritic pain

  2011cited by this paper
• Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1

  2011cited by this paper
• The precursor of resolvin D series and aspirin‐triggered resolvin D1 display anti‐hyperalgesic properties in adjuvant‐induced arthritis in rats

  2011cited by this paper
• Macrophage death and defective inflammation resolution in atherosclerosis

  2010cited by this paper
• Resolvin D1 binds human phagocytes with evidence for proresolving receptors

  2010cited by this paper
• Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1

  2010cited by this paper
• Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions

  2010cited by this paper
• Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti‐nociception

  2010cited by this paper
• Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

  2009cited by this paper
• Resolvins: Current understanding and future potential in the control of inflammation.

  2009cited by this paper
• Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography/electrospray ionisation tandem mass spectrometry.

  2008cited by this paper
• Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation

  2008cited by this paper
• Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

  2008cited by this paper
• Endogenous Receptor Agonists: Resolving Inflammation

  2007cited by this paper
• Endogenous lipid mediators in the resolution of airway inflammation

  2007cited by this paper
• Resolvin D1 and Its Aspirin-triggered 17R Epimer

  2007cited by this paper
• Resolution of in flammation: state of the art, definitions and terms

  2006cited by this paper
• Resolvin D Series and Protectin D1 Mitigate Acute Kidney Injury1

  2006cited by this paper
• Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes1

  2006cited by this paper
• Novel omega -- 3-derived local mediators in anti-inflammation and resolution.

  2005cited by this paper
• Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins

  2005cited by this paper
• Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.

  2004cited by this paper
• Resolvins

  2002cited by this paper
• Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing

  2000cited by this paper
• Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.

  1998cited by this paper
• Clinical Chemistry

  1989cited by this paper

• Herring roe PLs promote SPM biosynthesis in macrophages and a keratinocyte/fibroblast co-culture as model of psoriasis

  2026cites this paper
• The effect of DHA-rich algae oil supplementation in milk replacer on blood concentration of docosahexaenoic acid metabolites and cytokine production in white blood cells in calves.

  2025cites this paper
• Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives.

  2025cites this paper
• Effects of DHA Oral Supplementation on Plasma Resolvin D1 and D2 Levels in Naïve Breast Cancer Patients

  2025cites this paper
• Plasma oxylipins in children with sickle cell disease: Associations with biomarkers of inflammation and endothelial activation.

  2025cites this paper
• Specialized Pro-Resolving Lipid Mediators in Pulmonary Diseases: Molecular and Therapeutic Implications

  2025cites this paper
• RvD2 mitigates TNFɑ-Induced mitochondrial reactive oxygen species through NRF2 signaling in placental trophoblasts

  2025cites this paper
• From Fish Oil to Resolution: A Narrative Review on the Potential of SPM-Enriched Marine Oil for Exercise-Induced Muscle Damage Recovery

  2025cites this paper
• EPA, DHA, and resolvin effects on cancer risk: the underexplored mechanisms.

  2024cites this paper
• RVD2 emerges as a serological marker in relation to severity and six-month clinical outcome following acute intracerebral hemorrhage: A prospective cohort study from a single academic institution.

  2024cites this paper
• A potent proresolving mediator 17R-resolvin D2 from human macrophages, monocytes, and saliva

  2024cites this paper
• Omega-3 long-chain polyunsaturated fatty acids and their bioactive lipids: A strategy to improve resistance to respiratory tract infectious diseases in the elderly?

  2024cites this paper
• Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation

  2024cites this paper
• Oxylipin profiling for clinical research: Current status and future perspectives.

  2024cites this paper
• Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease

  2024cites this paper
• Omega-3 Futures in Aquaculture: Exploring the Supply and Demands for Long-Chain Omega-3 Essential Fatty Acids by Aquaculture Species

  2024cites this paper
• Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis

  2024cites this paper
• Proresolving Lipid Mediators in the Respiratory System.

  2024cites this paper
• Deciphering the Potential Role of Specialized Pro-Resolving Mediators in Obesity-Associated Metabolic Disorders

  2024cites this paper
• Technological Advancement in ω-3 fatty acids: its Therapeutic Functions and Novel Delivery Strategies.

  2023cites this paper
• Something Smells Fishy: How Lipid Mediators Impact the Maternal–Fetal Interface and Neonatal Development

  2023cites this paper
• Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis

  2023cites this paper
• Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis.

  2023cites this paper
• Role of Resolvins in Inflammatory and Neuropathic Pain

  2023cites this paper
• Influences of resolvin D1 and D2 on the risk of type 2 diabetes mellitus: a Chinese community-based cohort study

  2023cites this paper
• Is there a role for specialized pro-resolving mediators in pulmonary fibrosis?

  2023cites this paper
• Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study

  2023cites this paper
• Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects

  2023cites this paper
• Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

  2023cites this paper
• Effect of specialized pro-resolving lipid mediators in the regulation of vascular tone and inflammation in human saphenous vein.

  2023cites this paper
• Reply to: Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples

  2023cites this paper
• The role of efferocytosis‐fueled macrophage metabolism in the resolution of inflammation

  2023cites this paper
• Effects of polyunsaturated fatty acid supplementation on plasma and follicular fluid resolvin D1 concentration and mRNA abundance in granulosa cells in ewes.

  2023cites this paper
• Resolvin D2 uses multiple Ca2+‐dependent signaling pathways to stimulate mucin secretion in rat and human conjunctival goblet cells

  2022cites this paper
• Hydrolysis of polyhydroxy polyunsaturated fatty acid-glycerophosphocholines by Group IIA, V, and X secretory phospholipases A2.

  2022cites this paper
• Modifiable Innate Biology within the Gut–Brain Axis for Alzheimer’s Disease

  2022cites this paper
• Resolvin D1: A key endogenous inhibitor of neuroinflammation

  2022influential citation
• Lipid emulsion rich in n-3 polyunsaturated fatty acids elicits a pro-resolution lipid mediator profile in mouse tissues and in human immune cells.

  2022cites this paper
• Effects of forages, dust exposure and proresolving lipids on airway inflammation in horses

  2022cites this paper
• Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?

  2022cites this paper
• Evidence for the presence and diagnostic utility of SPM in human peripheral blood

  2022cites this paper
• Targeting Angiogenesis via Resolution of Inflammation.

  2022cites this paper
• Effects of fish oil-containing nutrition supplementation in adult sepsis patients: a systematic review and meta-analysis

  2022cites this paper
• Specialized pro-resolving mediators as modulators of immune responses.

  2022cites this paper
• E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition

  2022cites this paper
• The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review

  2022cites this paper
• Resolvins’ Obesity-Driven Deficiency: The Implications for Maternal–Fetal Health

  2022cites this paper
• Assessment of a combination of plasma anti-histone autoantibodies and PLA2/PE ratio as potential biomarkers to clinically predict autism spectrum disorders

  2022cites this paper
• Narrative Review of n-3 Polyunsaturated Fatty Acid Supplementation upon Immune Functions, Resolution Molecules and Lipid Peroxidation

  2021cites this paper
• Lipids: biomarkers of healthy aging

  2021cites this paper
• Lipid‐based regulators of immunity

  2021cites this paper
• Effects of forages, dust exposure and proresolving lipids on airway inflammation in horses.

  2021cites this paper
• The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD)

  2021cites this paper
• Glycated albumin as a biomarker for diagnosis of diabetes mellitus: A systematic review and meta-analysis

  2021cites this paper
• Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: Omega-3 long-chain polyunsaturated fatty acids

  2021cites this paper
• Omega‐3 carboxylic acids and fenofibrate differentially alter plasma lipid mediators in patients with non‐alcoholic fatty liver disease

  2021cites this paper
• Resolvin D1 reduces inflammation in co-cultures of primary human macrophages and adipocytes by triggering macrophages.

  2021cites this paper
• Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS

  2021cites this paper
• Effect of n-3 long-chain polyunsaturated fatty acid intake on the eicosanoid profile in individuals with obesity and overweight: a systematic review and meta-analysis of clinical trials

  2021cites this paper
• Association Between Daily Dietary Eicosatetraenoic Acid Intake and the Lower Risk of Psoriasis in American Adults

  2021cites this paper
• Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases

  2021cites this paper
• μSPE followed by HPLC-MS/MS for the determination of series D and E resolvins in biological matrices.

  2021cites this paper
• Neuroinflammation and its resolution in Alzheimer's disease

  2021cites this paper
• Role of Specialized Pro-Resolving Mediators in Modifying Host Defense and Decreasing Bacterial Virulence

  2021cites this paper
• N-3 Polyunsaturated Fatty Acids and Their Lipid Mediators as A Potential Immune–Nutritional Intervention: A Molecular and Clinical View in Hepatic Disease and Other Non-Communicable Illnesses

  2021cites this paper
• Novel Approaches for Omega-3 Fatty Acid Therapeutics: Chronic Versus Acute Administration to Protect Heart, Brain, and Spinal Cord.

  2020cites this paper
• Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?

  2020cites this paper
• Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy.

  2020cites this paper
• The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease

  2020cites this paper
• Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake.

  2020cites this paper
• Natural ligands of RXR receptors.

  2020cites this paper
• Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease

  2020cites this paper
• n-3 PUFA and inflammation: from membrane to nucleus and from bench to bedside

  2020cites this paper
• Rapid Metabolization of Protectin D1 by β -Oxidation of Its Polar Head Chain

  2020cites this paper
• Bioactive lipids, inflammation and chronic diseases.

  2020cites this paper
• Omega-3 (n-3) polyunsaturated fatty acids and inflammation: From membrane to nucleus and from bench to bedside

  2020cites this paper
• Research Online Research Online Pathological mechanisms and therapeutic outlooks for Pathological mechanisms and therapeutic outlooks for arthrofibrosis arthrofibrosis

  2020cites this paper
• Nutritional Lipids and Mucosal Inflammation.

  2020cites this paper
• N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation

  2019cites this paper
• Pro-resolving lipid mediators as therapeutic leads for cardiovascular diseases

  2019cites this paper
• The Influence of Omega-3 Fatty Acids on Skeletal Muscle Protein Turnover in Health, Disuse, and Disease

  2019cites this paper
• Pathological mechanisms and therapeutic outlooks for arthrofibrosis

  2019cites this paper
• Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease

  2019cites this paper
• Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma

  2019cites this paper
• Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system.

  2019cites this paper
• Effect of weight loss on neutrophil resolvins in the metabolic syndrome.

  2019cites this paper
• Lipidomic methodologies for biomarkers of chronic inflammation in nutritional research: ω-3 and ω-6 lipid mediators.

  2019cites this paper
• Omega-3 Fatty Acid-Derived Resolvin D2 Regulates Human Placental Vascular Smooth Muscle and Extravillous Trophoblast Activities

  2019cites this paper
• Eicosanoids in carcinogenesis

  2019cites this paper
• Oxidation products of arachidonic acid within lipoproteins and their effects on macrophage migration

  2019cites this paper
• Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples

  2019influential citation
• Omega-3 Fatty Acid Supplementation, Pro-Resolving Mediators, and Clinical Outcomes in Maternal-Infant Pairs

  2019cites this paper
• The Neuromodulatory Effects of ω-3 Fatty Acids and Nano-Curcumin on the COX-2/ iNOS Network in Migraines: A Clinical Trial Study from Gene Expression to Clinical Symptoms.

  2019cites this paper
• The role of omega 3 fatty acids in suppressing muscle protein catabolism: A possible therapeutic strategy to reverse cancer cachexia?

  2019cites this paper
• Resolvin D1 impacts on insulin resistance in women with polycystic ovary syndrome and healthy women.

  2019cites this paper
• Alternative retinoid X receptor (RXR) ligands.

  2019cites this paper
• Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome.

  2019cites this paper
• The Effect of Initial High vs. Low FiO2 on Breathing Effort in Preterm Infants at Birth: A Randomized Controlled Trial

  2019influential citation
• Fish Oil and Inflammation: A Perspective on the Challenges of Evaluating Efficacy in Trypanosoma cruzi Infection

  2019influential citation
• Resolvin D2 elevates cAMP to increase intracellular [Ca2+] and stimulate secretion from conjunctival goblet cells

  2019cites this paper